Multinational pharmaceutical companies are racking their brains trying to devise a solution with 'Sales cliff'

Multinational pharmaceutical companies are racking their brains trying to devise a solution with 'Sales cliff', which explains phenomenon that sales of original drugs fall sharply after patent expiration. The companies conduct additional clinical trials and announce the rusults, or invite foreign scholars and awaken original name value superior to generic. Also, they leave marketing sales to th...